Roth + Rau to Acquire 100% of OTB Solar

Roth & Rau AG is to take over from the OTB Group B.V., Eindhoven, Netherlands, 100% of the shares in that company´s subsidiary OTB Solar B.V. (OTB). OTB´s product portfolio consists of systems and technologies for the solar industry, especially antireflective coating systems and turnkey production lines for use in the manufacture of crystalline silicon solar cells. Moreover, OTB´s core competencies also include high-rate PECVD coating processes and industrial ink-jet printing applications with interesting potential for use in the production of new, high-efficiency solar cells.

The acquisition will enable Roth & Rau AG to increase its market share as an equipment supplier for crystalline solar technology and in its turnkey business. What´s more, the company has secured access to new competitive technologies and is thus pressing further ahead with expanding its product portfolio.

The purchase price amounts to € 35.5 million (including takeover of financial liabilities). Of this sum, an amount of € 30.0 million will be settled by issuing new Roth & Rau shares by way of a capital increase in return for non-cash contributions. The capital increase in return for non-cash contributions will be executed from Authorised Capital II to the exclusion of subscription rights. The new shares will be subject to a lockup period of 16 months following issue. The remaining € 5.5 million will be paid in cash. OTB had orders on hand of around € 50 million as of 31 January 2010. Accounting for the necessary restructuring charge, Roth & Rau AG expects to generate synergy effects in terms of costs and to see positive earnings contributions from OTB from the 2011 financial year onwards.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.